TScan Therapeutics Directors Garry Nicholson and Gabriela Gruia Resign

• TScan Therapeutics directors Garry Nicholson and Gabriela Gruia resigned from the board and all its committees effective October 13, 2026.
• Stephen Biggar joined the nominating and corporate governance committee effective October 13, 2026; R. Keith Woods became its chair.
• Neither resignation stemmed from disagreements over the company's operations, practices or policies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TScan Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-424198), on October 16, 2026, and is solely responsible for the information contained therein.